Author:
Beekman Rosalie R. A. L.,Duijkers Ruud R.,Snijders Dominic D.,van der Eerden Menno M.,Kross Martijn M.,Boersma Wim W. G.
Abstract
Abstract
Background
Legionella-related community acquired pneumonia (CAP) is a disease with an increasing incidence and a high mortality rate, especially if empirical antibiotic therapy is inadequate. Antibiotic treatment highly relies on clinical symptoms, although proven non-specific, because currently available diagnostic techniques provide insufficient accuracy for detecting Legionella CAP on admission. This study validates a diagnostic scoring system for detection of Legionella-related CAP, based on six items on admission (Legionella prediction score).
Methods
We included patients with Legionella-related CAP admitted to five large Dutch hospitals between 2006 and 2016. Controls were non-Legionella-related CAP patients. The following six conditions were rewarded one point if present: fever > 39.4 °C; dry cough; hyponatremia (sodium) < 133 mmol/L; lactate dehydrogenase (LDH) > 225 mmol/L; C-reactive protein (CRP) > 187 mg/L and platelet count < 171 × 109/L. The accuracy of the prediction score was assessed by calculating the area under the curve (AUC) through logistic regression analysis.
Results
We included 131 cases and 160 controls. A score of 0 occurred in non-Legionella-related CAP patients only, a score of 5 and 6 in Legionella-related CAP patients only. A cut-off ≥ 4 resulted in a sensitivity of 58.8% and a specificity of 93.1%. The AUC was 0.89 (95% CI 0.86–0.93). The strongest predictors were elevated LDH, elevated CRP and hyponatremia.
Conclusions
This multi-centre study validates the Legionella prediction score, an easily applicable diagnostic scoring system, in a large group of patients and finds high diagnostic accuracy. The score shows promise for future prospective validation and could contribute to targeted antibiotic treatment of suspected Legionella CAP.
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Phin N, Parry-ford F, Harrison T, Stagg HR, Zhang N, Kumar K, Lortholary O, Zumla A, Abubakar I. Epidemiology and clinical management of Legionnaires’ disease. Lancet Infect Dis. 2014;14:1011–21.
2. Marchello C, Dale AP, Thai TN, Han DS, Ebell MH. Prevalence of atypical pathogens in patients with cough and community-acquired pneumonia: a meta-analysis. Ann Fam Med. 2016;14:552–66.
3. Stout JE, Yu VL. Legionellosis. N Engl J Med. 1997;337:682–7.
4. Fang G-D, Fine M, Orloff J, Arisumi D, Yu VL, Kapoor W, Grayston JT, Wang SP, Kohler RB, Muder RR, Yee YC, Rihs JD, Vickers RM. New and emerging etiologies for community-acquired pneumonia with implications for therapy. Medicine (Baltimore). 1990;69:307–16.
5. Shah P, Barskey A, Binder A, Edens C, Lee S, Smith J, Whitney C, Cooley L, Cooley L. Legionnaires’ disease surveillance summary report, United States—2014 and 2015. 2018. https://www.cdc.gov/legionella/health-depts/surv-reporting/2014-15-surv-report-508.pdf. Accessed 1 Feb 2021.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献